Literature DB >> 12446462

Bcl-XL is required for heme synthesis during the chemical induction of erythroid differentiation of murine erythroleukemia cells independently of its antiapoptotic function.

Khalid Hafid-Medheb1, Yvette Augery-Bourget, Marie-Nathalie Minatchy, Nicole Hanania, Jacqueline Robert-Lézénès.   

Abstract

Bcl-X(L) is essential for the survival and normal maturation of erythroid cells, especially at the late stage of erythroid differentiation. It remains unclear whether Bcl-X(L) serves only as a survival factor for erythroid cells or if it can induce a signal for differentiation. We have previously shown that dimethyl sulfoxide (DMSO) induction of erythroid differentiation in murine erythroleukemia (MEL) cells correlates with delay of apoptosis and specific induction of Bcl-X(L). In this study, we investigate the contribution of Bcl-2 and Bcl-X(L) to survival and erythroid differentiation by generating stable MEL transfectants expressing these antiapoptotic regulators. Overexpression of Bcl-2 completely prevented apoptosis of MEL cells before and after DMSO induction, whereas overexpression of Bcl-X(L) only delayed it. Overexpression of Bcl-2 or Bcl-X(L) neither induced spontaneous erythroid differentiation nor accelerated DMSO-induced differentiation. Inhibition of Bcl-X(L) by antisense transcripts accelerated apoptosis in DMSO-treated MEL cells and blocked the synthesis of hemoglobin without altering the growth arrest associated with terminal erythroid differentiation. An antisense oligonucleotide to Bcl-X(L) did not induce apoptosis in MEL cells overexpressing Bcl-2 but greatly decreased their hemoglobin synthesis when treated with DMSO, suggesting that Bcl-X(L) is necessary for erythroid differentiation independently of its antiapoptotic function. Importantly, Bcl-X(L) antisense transcripts prevented heme synthesis but not globin mRNA induction in DMSO-treated MEL cells. Furthermore, inhibition of hemoglobin synthesis by Bcl-X(L) antisense was reversed by addition of exogenous hemin. Finally, Bcl-X(L) localized to mitochondria during MEL erythroid differentiation, suggesting that it may mediate a critical mitochondrial transport function related to heme biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446462     DOI: 10.1182/blood-2002-02-0478

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Vesicle trafficking plays a novel role in erythroblast enucleation.

Authors:  Ganesan Keerthivasan; Sara Small; Hui Liu; Amittha Wickrema; John D Crispino
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

2.  Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin.

Authors:  Melissa M Rhodes; Prapaporn Kopsombut; Maurice C Bondurant; James O Price; Mark J Koury
Journal:  Blood       Date:  2005-05-17       Impact factor: 22.113

3.  p73 plays a role in erythroid differentiation through GATA1 induction.

Authors:  Fernando Marqués-García; Nuria Ferrandiz; Rosalía Fernández-Alonso; Laura González-Cano; Marta Herreros-Villanueva; Manuel Rosa-Garrido; Belén Fernández-García; José P Vaque; Margarita M Marqués; María Eugenia Alonso; José Carlos Segovia; Javier León; María C Marín
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

Review 4.  Generation of erythroid cells from polyploid giant cancer cells: re-thinking about tumor blood supply.

Authors:  Zhigang Yang; Hong Yao; Fei Fei; Yuwei Li; Jie Qu; Chunyuan Li; Shiwu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-07       Impact factor: 4.553

5.  Cell survival under stress is enhanced by a mitochondrial ATP-binding cassette transporter that regulates hemoproteins.

Authors:  John Lynch; Yu Fukuda; Partha Krishnamurthy; Guoqing Du; John D Schuetz
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

6.  Identification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer.

Authors:  Anna-Lena Scherr; Andreas Mock; Georg Gdynia; Nathalie Schmitt; Christoph E Heilig; Felix Korell; Praveen Rhadakrishnan; Paula Hoffmeister; Klaus H Metzeler; Klaus Schulze-Osthoff; Anna L Illert; Melanie Boerries; Jörg Trojan; Oliver Waidmann; Johanna Falkenhorst; Jens Siveke; Philipp J Jost; Michael Bitzer; Nisar P Malek; Loredana Vecchione; Ivan Jelas; Benedikt Brors; Hanno Glimm; Albrecht Stenzinger; Svetlana P Grekova; Tobias Gehrig; Henning Schulze-Bergkamen; Dirk Jäger; Peter Schirmacher; Mathias Heikenwalder; Benjamin Goeppert; Martin Schneider; Stefan Fröhling; Bruno C Köhler
Journal:  Cell Death Dis       Date:  2020-10-17       Impact factor: 8.469

7.  Immortalization of erythroblasts by c-MYC and BCL-XL enables large-scale erythrocyte production from human pluripotent stem cells.

Authors:  Sho-Ichi Hirose; Naoya Takayama; Sou Nakamura; Kazumichi Nagasawa; Kiyosumi Ochi; Shinji Hirata; Satoshi Yamazaki; Tomoyuki Yamaguchi; Makoto Otsu; Shinya Sano; Nobuyasu Takahashi; Akira Sawaguchi; Mamoru Ito; Takashi Kato; Hiromitsu Nakauchi; Koji Eto
Journal:  Stem Cell Reports       Date:  2013-12-05       Impact factor: 7.765

8.  Phenolic acid content, antioxidant and cytotoxic activities of four Kalanchoë species.

Authors:  Anna Bogucka-Kocka; Christian Zidorn; Małgorzata Kasprzycka; Grażyna Szymczak; Katarzyna Szewczyk
Journal:  Saudi J Biol Sci       Date:  2016-02-01       Impact factor: 4.219

Review 9.  Alternative splicing of BCL-X and implications for treating hematological malignancies.

Authors:  Wanling Chen; Jinggang Li
Journal:  Oncol Lett       Date:  2021-07-18       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.